The Economic Burden of Diabetes

This Health Affairs article, based on a study headed by the Lewin Group, estimates the economic cost of diabetes in 2007.

The study, which asserted that diabetes was responsible for more than $218 billion in spending in 2007, drew from several government and private sources to derive this estimate—a combination of the cost of diabetes treatment and the loss of productivity from absenteeism estimated to be approximately $65 billion. In addition to the economic burden, the paper points to the rising levels of diabetes cases in the U.S. A subscription is required to read the full article, but the abstract can be accessed for free.

Read the abstract.